Using an emergency room for non-emergency treatment is more expensive for the patient and hospital, and places a strain the health care system. Click here to view original post… […]
NEEDHAM, Mass.–(BUSINESS WIRE)– #AxialFlux–Electric motor design and software company ECM PCB Stator Technology has re-located its headquarters to a newly constructed 6000 square feet corporate headquarters in Needham Heights, Massachusetts while also expanding its Bozeman, Montana operation into a new 5000 square feet facility. The centers empower ECM’s upcoming global… Click here to view original post… […]
Boston-based Oncorus is losing one-fifth of its employees as it pauses work on all but one drug. Click here to view original post… […]
According to a new poll released Wednesday, flexible working conditions, on-demand pay and tools to manage financial stress are priorities for health care workers and may be the key to recruiting and retaining health care staff as workforce shortages increase wait times and frustrations in Bay State hospitals. Click here to view original post… […]
In its third quarter report, Oncorus highlighted that it would report updated Phase I data on its lead candidate, an oncolytic virus therapy for solid tumors, before the end of the year. Now, that readout, pushed back to early 2023, will be the last for ONCR-177. Oncorus announced this morning… Click here to view original post… […]
X4 Pharmaceuticals said its rare disease drug cleared a Phase III on Tuesday afternoon, coming against a backdrop of layoffs and pipeline pruning earlier this year. In the topline results, the Boston biotech said its lead therapy mavorixafor, a CXCR4 antagonist which the biotech picked up from Sanofi, met… Click here to view original post… […]
WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know To Be Prepared for 2023” and its podcast episode “What Leaders In Life Sciences Need To Know To Be Prepared for 2023” based on highlights… Click here to view original post… […]
A closely watched new treatment for Alzheimer’s disease from Eisai and Biogen held up to scrutiny in a detailed scientific presentation. Click here to view original post… […]
CAMBRIDGE, Mass., Nov. 30, 2022 /PRNewswire/ — SurgiBox Inc. today announced CE Marking for its Smart Control Module 001-SCM-0000 and its Battery Pack BP-04002M. SurgiBox has obtained Humanitarian Use Exemption for the use of the SurgiField System in Ukraine. The Exemption stated that… Click here to view original post… […]
CAMBRIDGE, Mass., Nov. 30, 2022 /PRNewswire/ — Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that the first cohort has been dosed in a Phase 2 trial evaluating KP104 for the… Click here to view original post… […]
Copyright © 2022 Biotech Networks, LLC
